Siegel, D.S.
Weisel, K.
Zahlten-Kumeli, A.
Medhekar, R.
Sapra, S.
Ding, B.
Leleu, X.
This article is maintained by: Elsevier
Article Title: HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY COMPARING CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB TO CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.10.436
Content Type: simple-article
Copyright: Copyright © 2020 Published by Elsevier Editora Ltda.